Original Article

Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

Volume 37 · Issue 3 Publish Date: September 30, 2022
Full Text PDF HTML
DOI
Eman Eissa ORCID
Department of Immunogenetics, National Research Centre, Cairo, Egypt image/svg+xml
Botros Morcos ORCID
Department of Immunogenetics, National Research Centre, Cairo, Egypt image/svg+xml
Dalia Dorgham ORCID
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Cairo University, Cairo, Egypt image/svg+xml
Naglaa Kholoussi ORCID
Department of Immunogenetics, National Research Centre, Cairo, Egypt image/svg+xml
Eman Eissa, Botros Morcos, Dalia Dorgham, & Naglaa Kholoussi. (2022). Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients. Archives of Rheumatology, 37(3), 417–423. https://doi.org/10.46497/ArchRheumatol.2022.9217
Full Text PDF HTML

Abstract

Objectives: This study aims to evaluate the expression pattern of factor H in peripheral blood and the frequency of factor H autoantibodies in plasma of juvenile-onset systemic lupus erythematosus (jSLE) patients compared to healthy controls.

Patients and methods: Between March 2019 and October 2019, a total of 30 healthy individuals (3 males, 27 females; mean age: 26±7.4 years; range, 18 to 40 years) and 65 jSLE patients (age of onset ≤16 years) (2 males, 63 females; mean age: 23.4±7 years; range, 15 to 38 years) were included. Factor H expression pattern was examined in blood of all subjects using quantitative real-time polymerase chain reaction and the frequency of factor H autoantibodies was estimated in plasma using enzyme-linked immunosorbent assay.

Results: Factor H expression was significantly downregulated in jSLE patients compared to healthy controls (p<0.01). A significant underexpression of factor H was observed in jSLE patients with nephritis compared to those without nephritis (p<0.03), while there was no association of factor H expression levels with any of the other clinical and serological features, disease activity or disease damage index of patients. Only 5% of jSLE patients were positive for factor H autoantibodies without any correlations with the clinical data or disease activity of patients.

Conclusion: Our study results suggest that factor H expression can be dysregulated in jSLE patients.

Similar Articles

Article Info
Published In
Journal Archives of Rheumatology
Volume / Issue Volume 37 · Issue 3
Pages 417-423
History
Published Online September 30, 2022
License
Affiliations
Eman Eissa ORCID
Department of Immunogenetics, National Research Centre, Cairo, Egypt
Botros Morcos ORCID
Department of Immunogenetics, National Research Centre, Cairo, Egypt
Dalia Dorgham ORCID
Department of Rheumatology and Rehabilitation, Faculty of Medicine, Cairo University, Cairo, Egypt
Naglaa Kholoussi ORCID
Department of Immunogenetics, National Research Centre, Cairo, Egypt
Cite this Article
Eman Eissa, Botros Morcos, Dalia Dorgham, & Naglaa Kholoussi. (2022). Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients. Archives of Rheumatology, 37(3), 417–423. https://doi.org/10.46497/ArchRheumatol.2022.9217
Share
Outlines